These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21628369)

  • 1. Study subject to unmeasured confounders and biases.
    Szarewski A; Mansour D
    BMJ; 2011 May; 342():d3349. PubMed ID: 21628369
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thromboembolism is egregiously underestimated.
    Shapiro S
    BMJ; 2011 May; 342():d3344. PubMed ID: 21628367
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data.
    Jick SS; Hernandez RK
    BMJ; 2011 Apr; 342():d2151. PubMed ID: 21511805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
    Parkin L; Sharples K; Hernandez RK; Jick SS
    BMJ; 2011 Apr; 342():d2139. PubMed ID: 21511804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    Heinemann K; Heinemann LA
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
    [No Abstract]   [Full Text] [Related]  

  • 6. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral hormonal contraception and venous thromboembolism (VTE).
    Reid RL
    Contraception; 2014 Apr; 89(4):235-6. PubMed ID: 24594431
    [No Abstract]   [Full Text] [Related]  

  • 8. The INAS-OC study.
    Lidegaard O
    Contraception; 2014 Dec; 90(6):617-8. PubMed ID: 25261151
    [No Abstract]   [Full Text] [Related]  

  • 9. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to letter to the editor: "The INAS-OC study".
    Dinger J
    Contraception; 2014 Dec; 90(6):618-21. PubMed ID: 25263612
    [No Abstract]   [Full Text] [Related]  

  • 11. Drospirenone and VTE.
    Leppée M; Eric M; Culig J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):44. PubMed ID: 20067674
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraceptives and venous thromboembolism: pill scares and public health.
    Reid RL
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1150-5. PubMed ID: 22082790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 18. Drospirenone-related venous thromboembolism risk: "the rest of the story".
    Casey PM; Files JA; Mayer AP
    J Womens Health (Larchmt); 2013 May; 22(5):467-8. PubMed ID: 23659485
    [No Abstract]   [Full Text] [Related]  

  • 19. Yasmin and venous thromboembolism: new case reports.
    López M; Vayá A; Martínez Triguero ML; Contreras MT; Todolí J; Ricart A; Laiz B
    Clin Hemorheol Microcirc; 2009; 42(1):65-9. PubMed ID: 19363241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.